Categoría: News
-
Public Awareness of Cord Blood Opportunities Lagging
Recent studies indicate that a lack of public education about cord-blood-derived adult stem cells is hindering therapeutic progress.
-
Cells Reprogrammed With Single Gene
Scientists in Germany have simplified the iPS (induced pluripotent stem) cell reprogramming procedure from four genes to one gene, though the choice of cell type plays an important role.
-
Vet-Stem Offers New Adult Stem Cell Culturing Process
Vet-Stem, the highly successful U.S. veterinary adult stem cell company, now offers a service which allows for an "everlasting" supply of adult stem cells.
-
Geron Explains Delay in Trial
At last, for the first time, Geron offers an explanation for the FDA-imposed hold on its highly publicized human embryonic stem cell clinical trial.
-
Adult Stem Cells Treat Heart Failure
Doctors in Houston use autologous adult stem cell therapy to treat heart failure in an FDA-approved clinical trial.
-
Russian Stem Cell Company Plans IPO
Russia’s Human Stem Cell Institute has announced that it is seeking funding from investors in what promises to be Russia’s first initial public offering in over a year.
-
Skin Cells Turned into Retinal Cells
Through iPS cell technology, scientists turn ordinary skin cells into retinal cells.
-
New Adult Stem Cell Facility Opens in Maryland
The company RNL Biostar has announced the opening of a new adult stem cell R&D facility in Germantown, Maryland.
-
Olympic Medalist Endorses Cord Blood Bank
The Olympic medalist Shannon Miller has signed a marketing endorsement partnership with StemCyte, one of the world’s leading cord blood banks.
-
Four-Year Prison Term Sought in South Korea for Stem Cell Fraud
Prosecutors in South Korea have recommended a four-year prison term for Hwang Woo-suk, whose fraudulent stem cell reports caused an international scandal.